iridium has been researched along with Angiogenesis, Pathologic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albrecht, M; Brabec, V; Donnelly, K; Kasparkova, J; Mueller, T; Muenzner, JK; Novohradsky, V; Rehm, T; Schmitt, F; Schobert, R | 1 |
Bagowski, CP; Harms, K; Kräling, K; Meggers, E; Schmitz, DJ; Vlecken, DH; Wilbuer, A | 1 |
Di Fazio, P; Feng, L; Kastl, A; Meggers, E; Merkel, AL; Ocker, M; Wilbuer, A | 1 |
3 other study(ies) available for iridium and Angiogenesis, Pathologic
Article | Year |
---|---|
Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and gold.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chick Embryo; Gold; Humans; Imidazoles; Iridium; Melanoma; Mice; Neovascularization, Pathologic; Platinum; Ruthenium; Xenograft Model Antitumor Assays | 2016 |
Iridium complex with antiangiogenic properties.
Topics: Animals; Coordination Complexes; Crystallography, X-Ray; Embryo, Nonmammalian; Humans; Iridium; Models, Animal; Molecular Conformation; Neovascularization, Pathologic; Oxidation-Reduction; Protein Kinase Inhibitors; Protein Kinases; Stereoisomerism; Vascular Endothelial Growth Factor Receptor-3; Zebrafish | 2010 |
Dual anticancer activity in a single compound: visible-light-induced apoptosis by an antiangiogenic iridium complex.
Topics: Angiogenesis Inhibitors; Apoptosis; HeLa Cells; Humans; Iridium; Light; Neovascularization, Pathologic; Organometallic Compounds | 2012 |